Thanks for that ahjay,
Understand one needs to mind the amount of sodium chloride spinkled throughout these reports though take note that the price guess takes account of the fact -
.............IMP761 Phase I safety data in healthy volunteers, as IMM’s leading autoimmune-focused asset. This is not in themarket’s focus at all, nor in valuation at present............." - YET !!
Ann: Positive results in TACTI-003 for 1L HNSCC cohort B patients, page-40
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
-0.020(6.90%) |
Mkt cap ! $392.7M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 27.0¢ | $569.8K | 2.076M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 706076 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |